Merck KGaA's change in inventory for the quarter that ended in Mar. 2026 was CHF-131 Mil. It means Merck KGaA's inventory
increased by CHF131 Mil
from Dec. 2025 to Mar. 2026 .
Merck KGaA's change in inventory for the fiscal year that ended in Dec. 2025 was CHF-240 Mil. It means Merck KGaA's inventory
increased by CHF240 Mil
from Dec. 2024 to Dec. 2025 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Merck KGaA's Days Inventory for the quarter that ended in Mar. 2026 was 208.59.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Merck KGaA's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.44.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Merck KGaA's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.92.
Merck KGaA (XSWX:MER) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Merck KGaA's Days Inventory for the quarter that ended in is calculated as:
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Merck KGaA's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merck KGaA Change In Inventory Related Terms
Merck KGaA Change In Inventory Historical Data
* Premium members only.
The historical data trend for Merck KGaA's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-266 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Inventory of CHF-266 Mil mean?
Merck KGaA (XSWX:MER) has a Change In Inventory of CHF-266 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Merck KGaA and its competitors.
Is Merck KGaA's Change In Inventory too high?
Merck KGaA's current Change In Inventory is CHF-266 Mil. Overall, Merck KGaA has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Merck KGaA's Change In Inventory compare to ZTS and UTHR?
Merck KGaA's Change In Inventory of CHF-266 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Merck KGaA and its competitors. Merck KGaA's current Change In Inventory is CHF-266 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck KGaA stock overvalued right now?
Merck KGaA (XSWX:MER) has a current Change In Inventory of CHF-266 Mil. The stock's GF Value™ is CHF132.97, compared to a current price of CHF132.00 — trading 0.7% below its estimated fair value. The current Change In Inventory is CHF-266 Mil. Merck KGaA's overall GF Score™ is 82/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Merck KGaA (XSWX:MER), the current Change In Inventory is CHF-266 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merck KGaA (XSWX:MER) Overvalued in 2026?
Based on GuruFocus' analysis, Merck KGaA stock appears to be undervalued.
The current stock price of CHF132.00 is trading 0.7% below its estimated GF Value™ of CHF132.97.
Key valuation signals for XSWX:MER:
Change In Inventory: CHF-266 Mil
GF Value™: CHF132.97 vs. price of CHF132.00 (0.7% below fair value)
No single metric tells the full story. See the XSWX:MER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
82GF Score
Get the complete analysis for XSWX:MER
Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MER has been successfully added to your 
